DATA SHEET. Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA.

Similar documents
Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work

Management of NRTI Resistance

0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920

Clinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness

Supplementary Figure 1. Gating strategy and quantification of integrated HIV DNA in sorted CD4 + T-cell subsets.

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS

MedChem 401~ Retroviridae. Retroviridae

VIROLOGY. Engineering Viral Genomes: Retrovirus Vectors

I m B m. 1 f ub I B. D m B. f u. 1 f ua 1 D I A. I A m. D m A. f a. 1 f u. D m B ) D m A )(I m B. 1 f ua. 1 (I m A. log (I A. log f.

2 nd Line Treatment and Resistance. Dr Rohit Talwani & Dr Dave Riedel 12 th June 2012

VQA Control SOP Version 4.0 Roche Amplicor HIV-1 DNA Test, v August 2007

Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay

Recombinant Protein Expression Retroviral system

Antiviral Agents DEPARTEMEN FARMAKOLOGI & TERAPEUTIK FK USU. 06 August

Milan, Italy. Received 15 March 2002; returned 22 July 2002; revised 12 September 2002; accepted 27 September 2002

Certificate of Analysis

NNRTI Resistance NORTHWEST AIDS EDUCATION AND TRAINING CENTER

Introduction: Table/Figure Descriptions:

Antiviral Chemotherapy

Terapia antirretroviral inicial y de rescate: Utilidad actual y futura de nuevos medicamentos

Reverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

Continuing Education for Pharmacy Technicians

HIV Drugs and the HIV Lifecycle

NOTICE TO PHYSICIANS. Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases, National Institutes of Health

HIV and AIDS. Shan Nanji

DIVISION OF ANTIVIRAL DRUG PRODUCTS (HFD-530) MICROBIOLOGY REVIEW NDA:

Human Immunodeficiency Virus-1 (HIV-1) Genemer. Primer Pair for amplification of HIV-1 Specific DNA Fragment

HIV medications HIV medication and schedule plan

Anumber of clinical trials have demonstrated

Perspective Resistance and Replication Capacity Assays: Clinical Utility and Interpretation

VQA HIV DNA Control SOP Version 5.0 HIV DNA Testing 13 March 2012

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Certificate of Analysis

HIV-1 Genemer Detection Kit Ready to Use Amplification Kit for HIV-1 Specific DNA Fragment Analysis

Treatment of respiratory virus infection Influenza A & B Respiratory Syncytial Virus (RSV)

VIRAL TITER COUNTS. The best methods of measuring infectious lentiviral titer

Industry Data Request

Hepatitis B Virus Genemer

ORIGINAL ARTICLE /j x. Brescia, Italy

Sequences in the 5 and 3 R Elements of Human Immunodeficiency Virus Type 1 Critical for Efficient Reverse Transcription

Antiretroviral treatment outcomes after the introduction of tenofovir in the public-sector in South Africa

Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors

HIV - Life cycle. HIV Life Cyle

Second-Line Therapy NORTHWEST AIDS EDUCATION AND TRAINING CENTER

Trends in molecular diagnostics

HIV associated CNS disease in the era of HAART

Antiviral Drugs Lecture 5

AIDS - Knowledge and Dogma. Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/ , Vienna, Austria

Panther has new prey

HIV Update Objectives. Epidemiology. Epidemiology, Transmission and Natural History. Transmission Risk by Exposure. Transmission 9/29/2014

Because accurate and reproducible phenotypic susceptibility

Industry Request Integrase Inhibitors

HIV 101: Fundamentals of HIV Infection

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist

Retroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase.

Antiviral Therapy 2011; 16: (doi: /IMP1851)

Distribution and Effectiveness of Antiretrovirals in the Central Nervous System

HIV-1 Viral Load Real Time (RG)

Nobel /03/28. HIV virus and infected CD4+ T cells

Diagnostic Methods of HBV and HDV infections

Retro-X qrt-pcr Titration Kit User Manual

~Lentivirus production~

Case Study. Dr Sarah Sasson Immunopathology Registrar. HIV, Immunology and Infectious Diseases Department and SydPath, St Vincent's Hospital.

Somnuek Sungkanuparph, M.D.

Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid.

Characteristics and outcomes of individuals enrolled for HIV care in a rural clinic in Coastal Kenya Hassan, A.S.

Received 4 August 2005/Accepted 7 December 2005

Risk of HIV-1 low level viremia to treatment. Germany. Nadine Lübke Düsseldorf

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

HIV/AIDS CID 2003:37 (1 July) 113

Introduction to HIV Drug Resistance. Kevin L. Ard, MD, MPH Massachusetts General Hospital Harvard Medical School

Technical Bulletin No. 162

C h a p t e r 5 5 HIV Therapy Where are We Now?

Evaluation and Management of Virologic Failure

7.014 Problem Set 7 Solutions

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)

Received 21 April 2005/Accepted 21 June 2005

HIV epidemiology since HIV in the United States. HIV Transmission

Margaret A. Daugherty. Announcements! Fall Michaelis Menton Kinetics and Inhibition. Lecture 14: Enzymes & Kinetics III

Reverse transcription and integration

HIV-1 Dual Infection and Neurocognitive Impairment

Central Nervous System Penetration of ARVs: Does it Matter?

Packaging and Abnormal Particle Morphology

Molecular Diagnosis Future Directions

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

Clinical Management of HIV Drug Resistance

Fig. 1: Schematic diagram of basic structure of HIV

Technical Bulletin No. 161

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Norgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler

Norgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler

Chapter 49. Antiviral Agents

Viruses. Picture from:

HIV & AIDS: Overview

Introduction retroposon

Transcription:

Viral Load

DNA >> Standard

PCR standard 0 Copies Catalog Number: 1122 Lot Number: 150298 Release Category: A Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA. Description: 10 reactions of a negative control template for use alongside HIV-1 Z6 DNA PCR standards (Cat#'s 4676-4679). -80 o C. Contributor: Dr. Shirley Kwok and Dr. Cindy Christopherson, Roche Molecular Systems. Produced by the VQA Laboratory at Rush University Medical Center. References: Hart C, Chant S-Y, Kwok S, Sninsky J, Ou C-Y, Schochetman G. A replication-deficient HIV-1 DNA used for quantitation of the polymerase chain reaction (PCR). Nucleic Acids Research 18:4029-4030, 1990. Abstract Acknowledgment for publications should read "The following reagent was obtained through the NIH AIDS Reagent Program, DAIDS, NIAID, NIH: PCR Standard 0 copies (cat# 1122) from Dr. Shirley Kwok and Dr. Cindy Christopherson, Roche Molecular Systems." Also include the reference cited above in any publications. REV: 12/10/2017 Page 1 of 1

PCR Standards 1 Copy Catalog Number: 4676 Lot Number: 150299 Release Category: A Provided: 500 µl of HIV-1 Z6 DNA at 1 copy/50 µl in 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA. Description: 10 reactions of HIV-1 Z6 DNA at 1 copy/50 µl. -80 o C. Contributor: Dr. Shirley Kwok and Dr. Cindy Christopherson, Roche Molecular Systems. Produced by the VQA Laboratory at Rush University Medical Center. References: Hart C, Chant S-Y, Kwok S, Sninsky J, Ou C-Y, Schochetman G. A replication-deficient HIV-1 DNA used for quantitation of the polymerase chain reaction (PCR). Nucleic Acids Research 18:4029-4030, 1990. Abstract Acknowledgment for publications should read "The following reagent was obtained through the NIH AIDS Reagent Program, DAIDS, NIAID, NIH: PCR Standards 1 Copy (cat# 4676) from Dr. Shirley Kwok and Dr. Cindy Christopherson, Roche Molecular Systems." Also include the reference cited above in any publications. REV: 12/10/2017 Page 1 of 1

PCR Standards 20 Copies Catalog Number: 4677 Lot Number: 150300 Release Category: A Provided: 500 µl of HIV-1 Z6 DNA at 20 copies/50 µl in 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA. Description: 10 reactions of HIV-1 Z6 DNA at 20 copies/50 µl. -80 o C. Contributor: Dr. Shirley Kwok and Dr. Cindy Christopherson, Roche Molecular Systems. Produced by the VQA Laboratory at Rush University Medical Center. References: Hart C, Chant S-Y, Kwok S, Sninsky J, Ou C-Y, Schochetman G. A replication-deficient HIV-1 DNA used for quantitation of the polymerase chain reaction (PCR). Nucleic Acids Research 18:4029-4030, 1990. Abstract Acknowledgment for publications should read "The following reagent was obtained through the NIH AIDS Reagent Program, DAIDS, NIAID, NIH: PCR Standards 20 Copies (cat# 4677) from Dr. Shirley Kwok and Dr. Cindy Christopherson, Roche Molecular Systems." Also include the reference cited above in any publications. REV: 12/10/2017 Page 1 of 1

PCR Standards 50 Copies Catalog Number: 4678 Lot Number: 150301 Release Category: A Provided: 500 µl of HIV-1 Z6 DNA at 50 copies/50 µl in 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA. Description: 10 reactions of HIV-1 Z6 DNA at 50 copies/50 µl. -80 o C. Contributor: Dr. Shirley Kwok and Dr. Cindy Christopherson, Roche Molecular Systems. Produced by the VQA Laboratory at Rush University Medical Center. References: Hart C, Chant S-Y, Kwok S, Sninsky J, Ou C-Y, Schochetman G. A replication-deficient HIV-1 DNA used for quantitation of the polymerase chain reaction (PCR). Nucleic Acids Research 18:4029-4030, 1990. Abstract Acknowledgment for publications should read "The following reagent was obtained through the NIH AIDS Reagent Program, DAIDS, NIAID, NIH: PCR Standards 50 Copies (cat# 4678) from Dr. Shirley Kwok and Dr. Cindy Christopherson, Roche Molecular Systems." Also include the reference cited above in any publications. REV: 12/10/2017 Page 1 of 1

pvqa Catalog Number: 12666 Lot Number: 140382 Release Category: E Provided: 10µl at 10ng/µl in 10mM Tris. Description: A plasmid standard used for an HIV-1 mrna quantification assay. This assay utilizes a primer in the 3'LTR of HIV-1 and a poly-a anchored primer to specifically detect all poly-adenylated HIV-1 mrna species. The pvqa plasmid contains the last ~350 nucleotides of HIV-1 mrna as well as ~30 deoxyadenosine residues. Special Characteristics: This plasmid can be utilized as a DNA standard for qpcr reactions, or can be used as a template for in vitro transcription of an RNA standard for RT-qPCR. SEQUENCE -20 C Contributor: Dr. Robert Siliciano, Johns Hopkins School of Medicine References: Shan L, Rabi SA, Laird GM, Eisele EE, Zhang H, Margolick JB, Siliciano RF. A novel PCR assay for quantification of HIV-1 RNA. J Virol. 2013 Jun;87(11):6521-5. ABSTRACT Acknowledgment for publications should read "The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: Cat# 12666 pvqa from Dr. Robert Siliciano." Also include the reference cited above in any publications. REV: 12/10/2017 Page 1 of 2

REV: 12/10/2017 Page 2 of 2

PCR Standards 100 Copies Catalog Number: 4679 Lot Number: 150302 Release Category: A Provided: 500 µl of HIV-1 Z6 DNA at 100 copies/50 µl in 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA. Description: 10 reactions of HIV-1 Z6 DNA at 100 copies/50 µl. -80 C Contributor: Dr. Shirley Kwok and Dr. Cindy Christopherson, Roche Molecular Systems. Produced by the VQA Laboratory at Rush University Medical Center. References: Hart C, Chant S-Y, Kwok S, Sninsky J, Ou C-Y, Schochetman G. A replication-deficient HIV-1 DNA used for quantitation of the polymerase chain reaction (PCR). Nucleic Acids Research 18:4029-4030, 1990. Abstract Acknowledgment for publications should read "The following reagent was obtained through the NIH AIDS Reagent Program, DAIDS, NIAID, NIH: PCR Standards 100 Copies (cat# 4679) from Dr. Shirley Kwok and Dr. Cindy Christopherson, Roche Molecular Systems." Also include the reference cited above in any publications. REV: 12/10/2017 Page 1 of 1

HMA Kits >> Complete Kits

Heteroduplex Mobility Analysis HIV-1 gag Subtyping Kit Catalog Number: 5210 Lot Number: 9 Release Category: D Provided: The HMA Gag Kit includes primers, control plasmid DNA, and reference strains. Click here to view kit contents -70 C. Upon receipt, place the Primers and the Plasmids in separate boxes to avoid DNA cross contamination. Contributor: Drs. Leo Heyndrickx, Gert Van der Auwera, and Guido van der Groen. References: Website references: http://www.itg.be/internet/microbiol/gaghma/gaghmaeng5.pdf http://www.itg.be/internet/microbiol/gaghma/gaghmafr5.pdf Acknowledgment for publications should read "The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: HMA HIV-1 Gag Subtyping Kit from Drs. Guido van der Groen, Leo Heyndrickx and Gert Van der Auwera." REV: 12/10/2017 Page 1 of 1

Heteroduplex Mobility Analysis HIV-1 env Subtyping Kit Catalog Number: 2751 Lot Number: 140220 Release Category: D Provided: The HMA Kit contains primers, control plasmid DNA, and reference strains. Click here to view kit contents -70 C. Upon receipt, place the Primers and the Plasmids in separate boxes to avoid DNA cross contamination. Contributor: Dr. James Mullins References: Website reference: http://ubik.microbiol.washington.edu/hma/hma.htm Acknowledgment for publications should read "The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: HMA HIV-1 Env Subtyping Kit from Dr. James Mullins." REV: 12/10/2017 Page 1 of 1

OLA Kits >> All

OLA Kit for the Detection of HIV-1 Resistance Mutations to NRTIs Catalog Number: 7645 Lot Number: 140219 Release Category: A Provided: Each kit contains plasmids, primers, codon-specific oligonucleotides and control genomic DNA. Click here to view kit contents Description: Used for the detection of resistance mutations to nucleoside reverse transcriptase inhibitors (abacavir, didanosine, lamivudine, stavudine, tenofovir, zalcitabine, zidovudine). OLA Kit Manual v1.3-20 C Contributor: Dr. Ingrid Beck, Dr. Lisa Frenkel, and DAIDS, NIAID. Acknowledgment for publications should read The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: OLA Kit, NRTIs (Cat #7645) from Dr. Ingrid Beck and Dr. Lisa Frenkel. REV: 12/10/2017 Page 1 of 1

OLA KIT for the Detection of HIV-1 Resistance Mutations to NNRTIs Catalog Number: 7644 Lot Number: 3 130169 Release Category: A Provided: Each kit contains plasmids, primers, codon-specific oligonucleotides and control genomic DNA. Click here to view kit contents Description: Used for the detection of HIV-1 resistance mutations to non-nucleoside reverse transcriptase inhibitors (nevirapine, delavirdine, efavirenz) OLA Kit Manual v1.3-20 C Contributor: Dr. Ingrid Beck, Dr. Lisa Frenkel, and DAIDS, NIAID. Acknowledgment for publications should read The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: OLA Kit, NNRTIs (Cat #7644) from Drs. Ingrid Beck and Lisa Frenkel. REV: 12/10/2017 Page 1 of 1

OLA Kit for the Detection of HIV-1 Resistance Mutations to Protease Inhibitors Catalog Number: 7643 Lot Number: 3 Release Category: A Provided: Each kit contains plasmid DNAs, primers, codon-specific oligonucleotides and control genomic DNA. Click here to view kit contents Description: Used for the detection of HIV-1 resistance mutations to protease inhibitors (nelfinavir, saquinavir, indinavir, ritonavir, and amprenavir). OLA Kit Manual v1.3. -20 C Contributor: Drs. Ingrid Beck and Lisa Frenkel, and DAIDS, NIAID. Acknowledgment for publications should read The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: OLA Kit, Protease Inhibitors (Cat #7643), from Drs. Ingrid Beck and Lisa Frenkel. REV: 12/10/2017 Page 1 of 1

RNA >> Standard

AMΔHIV Catalog Number: 1913 Lot Number: 1 03/93 Release Category: A Provided: 1 ml cell-free virus Description: A 267 bp synthetic HIV-1MN gag sequence designed by Dr. Gregory Milman, DAIDS, NIAID, was cloned into the SalI-HindIII site of the retroviral vector pln6 by Drs. Janice Clements and Paula Pitha-Rowe (The Johns Hopkins University). Original Source: A 267 bp gag fragment (sequence supplied by Dr. Gregory Milman, DAIDS) was cloned into the synthetic HIV-1 MN SalI-HindIII sites of the retroviral vector plnl6. The viral particles were collected from infected PA317 cells transfected with the recombinant vector. Host: PA317 packaging cells. Titer: 2.0 x 10 7 copies/ml (Roche) 1.4 x 10 7 copies/ml (NASBA) Special Characteristics: This virus serves as an internal standard for detection of HIV RNA by RT-PCR. The gag fragment contains small deletions to distinguish it from wild type HIV-1 (see attached). SK38/SK39 or SK145/SK101 primers can be used for RT PCR. The amplified product can be distinguished from full-length HIV-1 gag RNA by liquid hybridizaion followed by gel electorphoresis. 1 µl of the virus is sufficient for PCR analysis and quantitation. Gag sequence Sterility: Negative for bacteria and mycoplasma. REV: 12/10/2017 Page 1 of 2

Liquid nitrogen. Contributor: Division of AIDS, NIAID, NIH, and Dr. Paula Pitha-Rowe. References: Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895-2902, 1986. Bender MA, Palmer TD, Gelinas RE, Miller AD. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J Virol 61:1639-1646, 1987. Acknowledgment for publications should read "The following reagent was obtained through the NIH AIDS Reagent Program, DAIDS, NIAID: AMΔHIV from Dr. Paula Pitha-Rowe." Also include the references cited above in any publications. REV: 12/10/2017 Page 2 of 2

HIV-1 VQA RNA Quantification Standard Catalog Number: 3443 Lot Number: 160004 Release Category: D Provided: 1.25 ml, 150,000 copies HIV-1 RNA/mL spiked into HIV negative human serum to obtain final concentration. Contains EDTA. Description: Quantified live infectious virus spiked into HIV negative human serum. Original Source: HIV-1 qualitative cultures from known positive donors. Special Characteristics: This virus concentrate can be used to quantify HIV-1 RNA for viral detection assays. Virus stock used for this standard is a pool of B subtype HIV cultured from the PBMCs of 5 separate HIV-infected donors who were naïve to antiretroviral treatment. The virus culture supernatants were clarified of all cellular material and pooled. The virus stock was diluted in a commercial pooled true normal serum that is also clarified by filtration and EDTA is added at a final concentration of 6mM to mirror negative human EDTA plasma. Liquid nitrogen. Contributor: DAIDS Virology Quality Assurance (VQA) Program, Rush Presbyterian-St. Luke s Medical Center, Chicago, IL. Director: Dr. James Bremer. References: Yen-Lieberman B, et al. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol 34:2695-2701, 1996. Abstract REV: 12/10/2017 Page 1 of 2

Acknowledgment for publications should read "The following reagent was obtained through the NIH AIDS Reagent Program, DAIDS, NIAID: HIV-1 VQA RNA Quantification Standard from the DAIDS Virology Quality Assurance (VQA) Program." Also include the reference cited above in any publications. REV: 12/10/2017 Page 2 of 2